Clinical Trials Browser

Not yet recruiting × Pancreatic Neoplasms × anlotinib × Clear all

NCT06621095 2024-10-01

Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms